Search filters

List of works by Gerburg M Wulf

Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer.

scientific article

Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice

scientific article published on March 11, 2011

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

scientific article published on 21 September 2021

Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial

scientific article published on 14 March 2019

PARP-inhibition reprograms macrophages toward an anti-tumor phenotype

scientific article published in 2022

Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.

scientific article

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

scientific article published on 05 July 2019

Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer

scientific article published on 19 March 2020

Response of Brain Metastases From PIK3CA-Mutant Breast Cancer to Alpelisib

scientific article published on 27 May 2020

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

scientific article published on 29 October 2020

The amplifier effect: how Pin1 empowers mutant p53

scientific article published on October 13, 2011

Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib

scientific article published on 19 November 2019